|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.25 EUR | +0.61% |
|
+2.48% | +3.12% |
| Apr. 16 | Svas Biosana increases profit in 2023; ex-dividend proposed | AN |
| Apr. 15 | Mib bullish; Leonardo on top | AN |
Svas Biosana S.p.A. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 54.94 million compared to EUR 43.84 million a year ago. Revenue was EUR 56.96 million compared to EUR 46.12 million a year ago.
Net income was EUR 2.29 million compared to EUR 1.72 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +3.12% | 47.54M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.07% | 26.48B | |
| +2.36% | 26.25B | |
| +12.96% | 24.62B |
SVAS BIOSANA S.P.A. 
